.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Predicting mortality risk is vital for managing patients with end-stage renal disease. Monitoring outcomes through tools like the N-SII in hemodialysis survival is becoming essential for personalized care. Recent research introduced a composite scoring system called the nutritional-systemic immune inflammation (N-SII) score. This metric combines the Geriatric Nutritional Risk Index (GNRI) and the systemic immune inflammation index (SII). Consequently, it offers clinicians a more robust way to evaluate long-term prognosis.
Researchers conducted a comprehensive review of 2,859 patients on maintenance hemodialysis. They aimed to identify indicators with superior prognostic accuracy. The study found that the N-SII composite score yielded an area under curve (AUC) of 0.850. This performance significantly outperformed the isolated use of GNRI or SII alone. Specifically, GNRI and SII achieved AUCs of 0.761 and 0.782, respectively. Moreover, the N-SII score proved effective in predicting mortality from various causes, including cardiovascular and cerebrovascular events.
The results emphasize the synergy between nutritional status and systemic inflammation. Malnutrition often exacerbates inflammatory responses, which then accelerates vascular damage. By integrating these two factors, the N-SII score provides a comprehensive risk profile. Therefore, healthcare providers can better stratify patients and prioritize those requiring aggressive nutritional support. Additionally, this score serves as a simple yet powerful tool for routine clinical practice.
The N-SII score is a composite index. It incorporates the Geriatric Nutritional Risk Index (GNRI), which measures nutritional status, and the systemic immune inflammation index (SII), which reflects inflammatory levels.
It integrates both nutrition and inflammation, which are two major factors driving mortality in dialysis patients. By combining them, it achieves higher accuracy than using either marker individually.
This score allows for better risk stratification. Consequently, doctors can identify high-risk patients more effectively and implement targeted interventions to improve long-term outcomes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replacement for professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The N-SII composite score, merging GNRI and SII, significantly enhances the prediction of long-term survival for patients on maintenance hemodialysis....
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Recent clinical studies reveal maternal autoantibodies targeting IL-1RA as potential triggers for preterm labor, opening avenues for targeted cytokine therapies. Concurrently, new perioperative findings show inhaled cannabis increases propofol requirements during upper endoscopy compared to oral edible consumption.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
